Ireland Senate Passes Bill to Raise Legal Age for Tobacco Sales to 21

Nov.08.2024
Ireland Senate Passes Bill to Raise Legal Age for Tobacco Sales to 21
The Irish Senate has passed the Public Health (Tobacco) (Amendment) Bill, raising the legal minimum age for the sale of tobacco products to 21.

According to Irish Central, on November 7th, the Irish Senate passed the Public Health (Tobacco) (Amendment) Bill for 2024, completing its legislative process in both houses of parliament. The bill will raise the minimum legal age for the sale of tobacco products to 21. The bill is now set to be submitted to the President for review and signing.

 

After the president signs, the law will take effect on February 1, 2028. The transition period before this is designed to ensure individuals currently aged between 18 and 21 who are eligible to purchase tobacco will not be affected.

 

The bill stipulates that current penalties will be expanded to include punishments for selling tobacco products to individuals under the age of 21. First-time offenders can be fined up to a maximum of 4000 euros or face six months in prison, or both.

 

Ireland's Department of Health said that this measure aims to accelerate the decline in adult smoking prevalence, which have remained at 18% for many years, and reduce child smoking rates to zero. 

 

If the bill is passed, Ireland will become the first country in the European Union to raise the legal age for tobacco sales to 21.

 

"Ireland has long been a world leader in tackling smoking, beginning with the workplace smoking ban in 2004 and continuing with a range of measures including restrictions around the sale, advertising and packaging of smoking products to make them less attractive and less available to young people," Ireland's Minister for Health Stephen Donnelly said.

 

"I look forward to seeing this measure enacted, to help our young people to avoid the lifetime of addiction and illness that tobacco smoking brings," he said.

 

Minister of State Colm Burke, responsible for public health and national drug strategy, said: "This measure will protect our young people from starting their adult lives with an addiction to a product that causes 76% of lung cancers here and kills half of those who use it.

 

"I have strongly supported its introduction from the beginning and I look forward to its enactment."

 

Ireland's Chief Medical Officer, Professor Mary Hogan, said: "The enactment of this legislation represents another significant step in our efforts to reduce smoking levels."

 

"Tobacco smoking continues to be the biggest risk factor driving disability and death combined in our country, placing a huge burden on our health service."

 

"This measure will contribute to eliminating that ongoing threat and will support people to follow healthier behaviours."

 

In December 2023, Donnelly commenced section 28 of the Public Health (Tobacco Products and Nicotine Inhaling Products) Act to prohibit the sale of nicotine-inhaling products such as e-cigarettes (commonly referred to as vapes) to persons under 18.

 

In May 2024, Donnelly implemented parts of the bill that banned the sale of tobacco and nicotine inhalation products through vending machines. In December, he signed a law imposing on-the-spot fines of 2,000 euros for the sale of such products to children. 

 

In addition, Northern Ireland Health Minister Mike Nesbitt has welcomed the introduction of the Tobacco and Vapes Bill at Westminster this week. The bill prohibits anyone born on or after January 1, 2009 will never be able to legally be sold cigarettes, but its implementation in Northern Ireland will be subject to the agreement of the NI Executive and support of the NI Assembly.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA officials said manufacturing consistency is a core prerequisite for ENDS PMTA reviews, not a procedural formality. During its February 10, 2026 roundtable, the agency outlined expectations for quality management systems, manufacturing documentation, nicotine control, stability studies, and risk mitigation, emphasizing that robust manufacturing evidence underpins determinations of whether products are appropriate for the protection of public health.
Feb.11
2Firsts Flash|PMI Reports 2025 Results as Smoke-Free Products Account for 41.5% of Net Revenues
2Firsts Flash|PMI Reports 2025 Results as Smoke-Free Products Account for 41.5% of Net Revenues
Philip Morris International reported full-year 2025 results on February 6, with smoke-free products accounting for 41.5% of adjusted net revenues, up from 38.7% a year earlier. Total net revenues rose 7.3% to $40.65 billion, while shipment volumes increased 1.4%, widening the gap between revenue and volume growth. Cigarette shipments declined as smoke-free volumes rose 12.8%, driven by heated tobacco, oral nicotine and e-vapor products. Results were released alongside a 9:00 a.m. EST webcast.
Feb.06
Kentucky to issue provisional state licenses to tobacco, nicotine and vapor retailers who applied before Jan. 1, 2026
Kentucky to issue provisional state licenses to tobacco, nicotine and vapor retailers who applied before Jan. 1, 2026
Kentucky will issue provisional state licenses to tobacco, nicotine and vapor product retailers that applied for a license with the Department of Alcoholic Beverage Control (ABC) before Jan. 1, 2026.
Dec.31 by 2FIRSTS.ai
Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model
The U.S. Food and Drug Administration has confirmed that six on! PLUS nicotine pouch products have received Marketing Granted Orders (MGO) through the PMTA pathway. The authorizations were completed under the agency’s nicotine pouch review pilot program in “record time,” with the FDA citing lower levels of harmful constituents while stressing that the decision applies only to the specified products and does not mean they are safe or FDA approved.
Regulations
Dec.20
Spain’s new e-cigarette e-liquid tax, in force since April 1, raises €26 million through November
Spain’s new e-cigarette e-liquid tax, in force since April 1, raises €26 million through November
Spain’s Tax Agency monthly collection report shows the new tax on e-cigarette e-liquids, in force since April 1, raised €26 million through November, including €4 million in November. The levy began three months later than the usual fiscal timetable to allow the sector to adapt, making 2025 the first year in which vaping products are taxed under a specific category.
Dec.30 by 2FIRSTS.ai
Walgreens Brings Vapes Back to Some U.S. Stores; Juul Says It’s in or Near 6,000 Locations
Walgreens Brings Vapes Back to Some U.S. Stores; Juul Says It’s in or Near 6,000 Locations
Walgreens has begun selling vape products again in some U.S. stores, marking a notable reversal after the chain pulled vapes from shelves in 2019 amid concerns over youth use and health risks. Juul says it is expanding across thousands of Walgreens locations, and NJOY also lists Walgreens stores as retailers.
Jan.26 by 2FIRSTS.ai